Cyclooxygenase 2 Inhibitors: all 667 studies that test it

Page 7 of 7. Open to participants first (39), then studies with results posted, then the rest; newest registration first within each.

• A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-183)CompletedNCT00092326Phase 3
• A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-181)(COMPLETED)CompletedNCT00092300Phase 3
• Celecoxib and Erlotinib in Treating Former Smokers With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00088959Phase 1
• Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the ColonCompletedNCT00085163Phase 3
• Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal CancerCompletedNCT00084721Phase 1
• Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the BladderWithdrawnNCT00084578Not applicable
• Paclitaxel and Celecoxib in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal CancerTerminatedNCT00084448Phase 2
• Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic OophorectomyWithdrawnNCT00084370Not applicable
• Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the RectumTerminatedNCT00081224Phase 2
• Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone MetastasesTerminatedNCT00080782Phase 2
• Vinorelbine and Celecoxib in Treating Women With Relapsed or Metastatic Breast CancerTerminatedNCT00075673Phase 1
• Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical ProstatectomyTerminatedNCT00073970Phase 2
• Combination Chemotherapy and Celecoxib in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00073866Phase 1/2
• Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal CancerStatus unknownNCT00072553Phase 2
• S0212 Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the CervixWithdrawnNCT00072540Phase 2
• Celecoxib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00072072Phase 1
• Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00070486Phase 2
• Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast CancerCompletedNCT00070057Phase 1
• Gefitinib and Celecoxib in Treating Patients With Refractory Non-Small Cell Lung CancerCompletedNCT00068653Phase 2
• Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00068432Phase 2
• Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the EsophagusCompletedNCT00066716Phase 2
• Treatment of Diabetic NephropathyTerminatedNCT00065559Not applicable
• Delaying Alzheimer Disease Symptoms With Anti-Inflammatory DrugsCompletedNCT00065169Not applicable
• Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal CancerCompletedNCT00064181Phase 3
• Paclitaxel and Carboplatin With or Without Celecoxib Before Surgery in Treating Patients With Stage IIIA Non-Small Cell Lung CancerCompletedNCT00062179Phase 2
• Erlotinib and Celecoxib in Treating Patients With Stage IIIB or Stage IV Recurrent Non-Small Cell Lung CancerCompletedNCT00062101Phase 2
• Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid CancerCompletedNCT00061906Phase 2
• Treatment With MK0966 for the Prevention of Prostate Cancer (0966-201)CompletedNCT00060476Phase 3
• Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung CancerCompletedNCT00058006Phase 2
• Epirubicin and Celecoxib in Treating Patients With Hepatocellular CarcinomaCompletedNCT00057980Phase 1/2
• Celecoxib in Preventing Breast Cancer in At-Risk Premenopausal WomenCompletedNCT00056082Phase 2
• Celecoxib in Preventing Lung Cancer in Former Heavy SmokersCompletedNCT00055978Phase 2
• Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck DysplasiaCompletedNCT00052611Phase 2
• Laser and Medical Treatment of Diabetic Macular EdemaCompletedNCT00050479Phase 3
• Rofecoxib and Bupivacaine to Prevent Pain After Third Molar (Wisdom Tooth) ExtractionCompletedNCT00050362Phase 2
• Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00047294Phase 2
• Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant GliomaCompletedNCT00047281Phase 2
• Celecoxib in Treating Women With Metastatic or Recurrent Breast CancerTerminatedNCT00045591Phase 2
• Celecoxib to Treat Macular Degeneration in Patients Receiving Photodynamic TherapyCompletedNCT00043680Phase 2
• Celecoxib in Preventing Cancer in Patients With Rectal Polyps or Colorectal NeoplasiaCompletedNCT00043043Phase 2
• A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid ArthritisCompletedNCT00042068Phase 3
• Study of Vioxx and Radiation Therapy for Brainstem GliomaTerminatedNCT00038389Phase 1
• Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural MalignanciesCompletedNCT00037817Phase 1
• For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With ChemotherapyTerminatedNCT00037180Phase 2
• Chemoprevention of Oral Premalignant LesionsCompletedNCT00036283Phase 2
• Meloxicam [Mobic] in Juvenile Rheumatoid Arthritis (JRA)CompletedNCT00034853Phase 3
• Rofecoxib After Surgery in Treating Patients With Stage II or Stage III Colorectal CancerCompletedNCT00031863Phase 3
• Celecoxib and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00030420Phase 2
• Celecoxib and Docetaxel in Treating Patients With Non-Small Cell Lung CancerCompletedNCT00030407Phase 2
• Celecoxib in Preventing Skin Cancer in Patients With Actinic KeratosesWithdrawnNCT00027976Phase 2/3
• Rofecoxib to Prevent Pain After Third Molar (Wisdom Tooth) ExtractionCompletedNCT00026819Phase 2
• Celecoxib in Preventing Skin CancerWithdrawnNCT00025051Phase 2
• Radiation Therapy Plus Celecoxib, Fluorouracil, and Cisplatin in Patients With Locally Advanced Cervical CancerCompletedNCT00023660Phase 1/2
• Celecoxib in Preventing Basal Cell Carcinoma in Patients With Basal Cell Nevus SyndromeCompletedNCT00023621Phase 2
• Celecoxib Compared With No Treatment Before Surgery in Treating Patients With Localized Prostate CancerCompletedNCT00022399Phase 2
• Valdecoxib in Treating Chronic Pain in Cancer PatientsCompletedNCT00021996Not applicable
• Celecoxib in Preventing Non-Small Cell Lung Cancer in Tobacco SmokersCompletedNCT00020878Phase 2
• Celecoxib in Treating Patients With Precancerous Lesions of the MouthCompletedNCT00014404Phase 2
• Anti-Inflammatory Treatment for Age-Associated Memory Impairment: A Double-Blind Placebo-Controlled TrialCompletedNCT00009230Phase 3
• Celecoxib and Trastuzumab in Treating Women With Metastatic Breast CancerCompletedNCT00006381Phase 2
• Celebrex for Pain Relief After Oral SurgeryCompletedNCT00006299Phase 2
• Celecoxib in Treating Patients With Bladder CancerCompletedNCT00006124Phase 2/3
• Celecoxib to Prevent Cancer in Patients With Barrett's EsophagusCompletedNCT00005878Phase 2
• Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove PolypsCompletedNCT00005094Phase 3
• A Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease (NSAID Study)CompletedNCT00004845Phase 2/3
• Study of Etanercept and Celecoxib to Treat Temporomandibular Disorders (Painful Joint Conditions)CompletedNCT00001955Phase 2
• Phase I-II Multiple-Dose Safety and Efficacy Study of a Selective Inhibitor of Cyclooxygenase - 2 (SC-58635) in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients and CarriersCompletedNCT00001693Phase 1

← Cyclooxygenase 2 Inhibitors overview